Want to see TSE:CDVA full AI Analyst Report?
CDVA Stock Chart & Stats
C$0.02
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.02
C$0.00(0.00%)
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.08
Previous CloseN/A
Volume0.00
Average Volume (3M)44.87K
Market Cap
C$1.65M
Enterprise ValueC$10.15M
Total Cash (Recent Filing)C$515.15K
Total Debt (Recent Filing)C$5.17M
Price to Earnings (P/E)―
Beta4.68
Next Earnings
Nov 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding109,803,460
10 Day Avg. Volume14,141
30 Day Avg. Volume44,872
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)-1.04
Price to Sales (P/S)0.42
P/FCF Ratio5.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Operating ProfitabilityEBIT turning positive versus 2023 reflects durable improvement in core operations and cost control, indicating the business can generate operating profits before financing. This reduces dependence on external funding over time and validates operational fixes or product mix changes that management executed.
Positive Operating And Free Cash FlowConsistent positive operating and free cash flow, even if modest, is a structural shift from prior negative cash flows. It underpins internal funding for working capital and de-risks short-term financing needs, improving the company's ability to sustain operations and pursue incremental investments without immediate dilution.
Lean Operating Footprint (small Headcount)A small workforce suggests a lean cost base and operational flexibility, which can preserve cash burn and enable faster adjustment to demand or R&D priorities. For a specialty/generic drug maker, low fixed labor costs support scalability and reduce the runway needed to reach sustainable margins.
Bears Say
Negative Shareholders' EquityPersistently negative equity is a structural capital impairment that constrains financial flexibility, increases refinancing and dilution risk, and limits use of equity as a buffer against losses. It makes credit access harder and raises the probability that future capital raises dilute existing holders.
Meaningful Debt Load Vs Impaired EquityA meaningful debt burden relative to a small asset base and negative equity elevates refinancing and interest coverage risks. Servicing debt can constrain investment in growth or R&D, and with limited equity cushion the company may need dilutive financing if cash flow slips or creditors demand tighter terms.
Low Gross Margins And Ongoing Net LossesLow gross margins in a specialty/generic drug business limit the scope to absorb SG&A or R&D and make profitability fragile. Even with EBIT improvement, the -19% net margin shows profitability hasn't stabilized; margin pressure from pricing or cost increases would quickly reverse recent improvements.
CordovaCann News
CDVA FAQ
What was CordovaCann Corp.’s price range in the past 12 months?
CordovaCann Corp. lowest stock price was <C$0.01 and its highest was C$0.08 in the past 12 months.
What is CordovaCann Corp.’s market cap?
CordovaCann Corp.’s market cap is C$1.65M.
When is CordovaCann Corp.’s upcoming earnings report date?
CordovaCann Corp.’s upcoming earnings report date is Nov 02, 2026 which is in 102 days.
How were CordovaCann Corp.’s earnings last quarter?
CordovaCann Corp. released its earnings results on May 28, 2026. The company reported -C$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.002.
Is CordovaCann Corp. overvalued?
According to Wall Street analysts CordovaCann Corp.’s price is currently Overvalued.
Does CordovaCann Corp. pay dividends?
CordovaCann Corp. does not currently pay dividends.
What is CordovaCann Corp.’s EPS estimate?
CordovaCann Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CordovaCann Corp. have?
CordovaCann Corp. has 109,803,460 shares outstanding.
What happened to CordovaCann Corp.’s price movement after its last earnings report?
CordovaCann Corp. reported an EPS of -C$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of CordovaCann Corp.?
Currently, no hedge funds are holding shares in TSE:CDVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CordovaCann Corp.
CordovaCann Corp. is a company that focuses on various aspects of the cannabis industry, including identifying prospects, securing financing, developing new ventures, and managing operations throughout the entire cannabis value chain. As of February 14, 2022, it oversaw 14 retail outlets operating under the Star Buds Cannabis Co. brand. These stores are located in the Canadian provinces of Ontario, Manitoba, Alberta, and British Columbia, as well as the U.S. states of Oregon and Washington. The company, whose previous name was LiveReel Media Corporation, officially changed to CordovaCann Corp. in January 2018. Its corporate headquarters are situated in Toronto, Canada.